Treatment of herpes zoster infections or post-herpetic neuralgia by once-daily oral administration of brivudine, giving superior results to higher dose and more frequent administration of acyclovir

摘要

A pharmaceutical composition (A), for once-daily oral administration in the treatment of herpes zoster infections or post-herpetic neuralgia, contains brivudine (I) (as active agent) together with carrier and excipients.